{
    "organizations": [],
    "uuid": "7973aaffde64ab09a14f94ec66e12e3231acff22",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-boya-bio-pharmaceutical-group-unit/brief-boya-bio-pharmaceutical-group-unit-receives-gmp-certificate-idUSL4N1PX37C",
    "ord_in_thread": 0,
    "title": "BRIEF-Boya Bio-pharmaceutical Group unit receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7(Reuters) - Boya Bio-pharmaceutical Group Co Ltd\n* Says coâ€™s Nanjing-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, regarding small-volume injection, tablet, hard capsule and bulk drug\n* Says the valid period is until Feb. 4, 2023\nSource text in Chinese: goo.gl/tRTiuu\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-07T16:20:00.000+02:00",
    "crawled": "2018-02-09T06:05:54.044+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "boya",
        "group",
        "co",
        "ltd",
        "say",
        "co",
        "pharmaceutical",
        "unit",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "jiangsu",
        "food",
        "drug",
        "administration",
        "regarding",
        "injection",
        "tablet",
        "hard",
        "capsule",
        "bulk",
        "drug",
        "say",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}